Global University Venturing

UNC Chapel Hill’s agricultural technology developer AgBiome has increased its overall funding to $230m following the series D round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.

Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.

Raghupathy “Siva” Sivakumar has been appointed as the university’s inaugural vice-president of commercialisation and chief commercialisation officer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.

Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Cardiff University has become the sixth institution to join the partnership, having already collaborated on one programme for three years.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.